Impact of the COVID-19 pandemic and vaccination on global, regional, and national burden of Guillain-Barré syndrome: observational study

Xīn Gào, Chen Zhao, Junting Yang, Ziming Yang, et. al. ,doi: https://doi.org/10.1101/2024.07.09.24309613 Objectives To estimate the global, regional, and national burden and trends of Guillain-Barré Syndrome (GBS), and to explore the impact of the COVID-19 pandemic and related public health…[...]

Read More

The Incidence of Myocarditis and Pericarditis in Post COVID-19 Unvaccinated Patients—A Large Population-Based Study

Authors: Ortal Tuvali 1,†,Sagi Tshori 2,†,Estela Derazne 3,et. al. Abstract Myocarditis and pericarditis are potential post-acute cardiac sequelae of COVID-19 infection, arising from adaptive immune responses. We aimed to study the incidence of…[...]

Read More

Pfizer/BioNTech SARS-CoV-2 vaccine as a potential trigger for the development of narcolepsy: a case report

Ala Mahamid 1, Robyn Jacob Bornstein 2, Hagay Amir 3 PMID: 35733336 PMCID: PMC9516586 DOI: 10.5664/jcsm.10134 J Clin Sleep Med. 2022 Oct 1;18(10):2503-2506. doi: 10.5664/jcsm.10134. Abstract Narcolepsy is a rare condition in Israel. Currently, the incidence of narcolepsy following SARS-CoV-2…[...]

Read More

How compensation could be given to thousands of people left ‘disabled’ by the AstraZeneca Covid jab

By Xantha Leatham, Deputy Science Editor, 27 October 2024 Covid vaccine compensation could be given to thousands left 'disabled' by the AstraZeneca jab, it has emerged. Health Secretary Wes Streeting is understood to be considering…[...]

Read More

Outcome of Glomerular Disease Manifesting After Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2

Shuvam Roy • Anupma Kaul • Monika Yachha • et. al. Published: July 03, 2024, DOI: 10.7759/cureus.63767  Abstract Introduction Vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can upregulate the immune system and may contribute to glomerular…[...]

Read More

Transient Hyperglycemia in a Patient With Type 2 Diabetes After COVID-19 Messenger RNA Vaccination: A Case Report

Aniebietabasi Okon-Umoren • Sean Yaphe • Andrea Smith • Karla D. Passalacqua • Katarzyna Budzynska, Published: July 06, 2024, DOI: 10.7759/cureus.63983  Abstract The development of new vaccines against the SARS-CoV-2 virus in response to the COVID-19 pandemic represents a milestone…[...]

Read More